Fundraising Fox
🦊/Companies
Sign in

Biocytogen

Beijing, CN · 2 known investors

Find your way into Biocytogen

59 people in our graph share verified history with the Biocytogen team — schools, employers, funds. One of them is your warm intro.

Konstantinos Aprilakisunlockedknows Yuelei Shen · together at Howard Hughes Medical Institute (overlapped)
×6knows the team · via Howard Hughes Medical Institute
knows the team · via UMass Chan Medical School
×4knows the team · via Wuhan University

Biocytogen (HKEX: 02315) is a global biotechnology company that uses genetically engineered mouse models and its RenMice/RenMab/RenNano fully human antibody platforms to develop therapeutic antibody drugs. It provides antibody discovery, humanized mouse models (e.g. B-NDG, immune checkpoint humanized mice), and preclinical pharmacology and CRO services to biopharma clients worldwide.

BiotechDeep TechHealthtech

Founders & leadership

YSYuelei Shen
Yuelei SheninFounder · CEOYuelei Shen founded Biocytogen in 2008 in the United States, establishing its China operations in Beijing in 2009. Shen has expertise in immunology, autoimmune disease research, mouse gene targeting, infectious disease research, and antibody drug development.

Investors · 2

Cowin Capital GroupShenzhen · $1.4M – $50M
SDIC Venture CapitalreportedBeijing

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Competitors · 1

by search overlap
Taconic Biosciences4 shared keywordsTaconic Biosciences provides genetically engineered mouse and rat models, humanized immune system mice, custom model generation, colony management, and in vivo research services. It serves drug discovery and preclinical researchers, offering integrated laboratory animal models and services from model selection through study-ready cohorts.

Companies competing with Biocytogen for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Biocytogen Completes a New Round of Financing Totaling Tens of Millions of Dollarsprnewswire.com · Jun 2021Biocytogen Raises USD142M in Funding - FinSMEsfinsmes.com · Sep 2020China's Biocytogen gets $78m Series D | AVCJavcj.com · Aug 2019Chinese biotech firm Biocytogen raises $65m | AVCJavcj.com · Apr 2018

Frequently asked questions

What does Biocytogen do?
Biocytogen (HKEX: 02315) is a global biotechnology company that uses genetically engineered mouse models and its RenMice/RenMab/RenNano fully human antibody platforms to develop therapeutic antibody drugs. It provides antibody discovery, humanized mouse models (e.g. B-NDG, immune checkpoint humanized mice), and preclinical pharmacology and CRO services to biopharma clients worldwide.
Who founded Biocytogen?
Biocytogen was founded by Yuelei Shen.
Who are Biocytogen's investors?
Biocytogen's investors include Cowin Capital Group, SDIC Venture Capital.
Where is Biocytogen headquartered?
Biocytogen is headquartered in Beijing, CN.